No Data
No Data
Express News | ApicHope Pharmaceutical: The enrollment for the pivotal global Phase III REDUCE2 trial of the Innovative Drugs AR882 has surpassed half.
binhai inv's self-developed innovative products made a stunning debut at the gas exhibition.
On November 4th, 2024, at the 26th China International Gas, Heating Technology and Equipment Exhibition, Binhai Investment's subsidiary, Tianjin Binhai Investment New Wisdom Technology Co., Ltd. (Binhai New Wisdom), joined hands with strategic partner Shanghai Zenlan Instrument Technology Co., Ltd. (Shanghai Zenlan) to showcase Binhai New Wisdom's self-developed innovative products and solutions for the first time at this exhibition. The new products integrate technologies such as Internet of Things, cloud computing, big data, and artificial intelligence, which can achieve real-time monitoring of important scenarios such as gas pipelines, valve wells, and pressure regulating cabinets. In case of emergencies such as gas leaks, abnormal pressure, and third-party construction damage in the gas pipeline network.
Kensoh: Half Year Report - Term 54 (2024/04/01 - 2025/03/31)
Kensoh: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending 2025/3 [Japanese GAAP] (unconsolidated)
No schedule (21st) [Financial schedule]
※The above calendar is just a schedule and may be subject to change depending on the company's circumstances.---------------------------------------October 21st (Mon)---------------------------------------October 22nd (Tue) <8218> Komeri <9278> Book Off GHD <9691> Ryomo System---------------------
Express News | Qingyan Environment: Qingyan Venture, a shareholder holding more than 5% of the shares, plans to reduce its shareholding by no more than 2.95%.
No Data